Syntropac 250 mcg Injection contains tetracosactide, a synthetic analogue of adrenocorticotropic hormone (ACTH). It stimulates the adrenal cortex to produce corticosteroid hormones, including cortisol, helping healthcare professionals evaluate adrenal gland function.
Syntropac is used as a diagnostic aid when investigating suspected adrenal insufficiency, commonly through an ACTH stimulation test. Cortisol levels are measured before and after administration according to the prescribed diagnostic protocol.
Syntropac contains the same active ingredient as Synacthen 250 mcg injection and may be considered an alternative product where appropriately authorized. However, generic status, interchangeability and market availability must be confirmed for the specific product and destination country.
Syntropac 250 mcg Injection may be used by healthcare professionals for:
Test results must be interpreted by a qualified healthcare professional alongside the patient’s medical history, laboratory findings and applicable diagnostic criteria.
Syntropac 250 mcg Injection must be administered by a qualified healthcare professional according to the approved product instructions and the applicable clinical protocol.
A commonly used short ACTH stimulation test involves a single 250 mcg dose, with cortisol measurements taken before administration and at specified intervals afterward. The exact administration route, timing of blood samples and interpretation criteria should follow the local diagnostic protocol.
Do not self-administer this medicine or use it for repeated treatment without specialist direction. Confirm the exact product formulation and administration instructions before use.
Possible adverse effects include:
Serious allergic reactions, including anaphylaxis, may occur. Administration should take place in a suitable clinical setting where the patient can be observed and emergency treatment is available.
Seek immediate medical assistance for difficulty breathing, swelling of the face or throat, widespread hives, collapse or other signs of a severe allergic reaction.
Before administration, the healthcare professional should review the patient’s medical history, previous reactions to ACTH preparations and relevant current medicines.
Important precautions include:
Refer to the exact product leaflet for all contraindications, warnings and precautions.
Store Syntropac according to the manufacturer’s instructions on the actual product packaging and leaflet. Verify the required temperature range, protection from light and expiry date before use.
If refrigerated storage or cold-chain transport is specified, those conditions must be maintained during storage and shipping. Do not use damaged, expired or improperly stored ampoules.
Syntropac and Synacthen 250 mcg ampoules contain tetracosactide, a synthetic ACTH analogue used in diagnostic assessment of adrenal function.
The same active ingredient and strength do not independently establish legal generic substitution. Confirm the manufacturer’s details, formulation, official product information and regulatory status before listing or supplying Syntropac as a generic equivalent.
For Syntropac 250 mcg Injection pricing, ampoule sizes and availability, contact the supplier to confirm the exact product, manufacturer, packaging and current stock.
Product authorization, prescription requirements and import eligibility vary by country. Verify local requirements and any necessary storage or cold-chain arrangements before ordering.
1. What is Syntropac 250 mcg Injection used for?
It is a diagnostic medicine used to help assess adrenal gland function, particularly when investigating suspected adrenal insufficiency.
2. What is the active ingredient in Syntropac?
The active ingredient is tetracosactide, a synthetic ACTH analogue.
3. Is Syntropac a generic for Synacthen?
Syntropac contains the same active ingredient as Synacthen 250 mcg injection. Whether it is officially classified as a generic or approved as an interchangeable alternative depends on the relevant country’s regulatory requirements.
4. What is the strength of Syntropac Injection?
The commonly listed presentation contains 250 mcg of tetracosactide in a 1 mL ampoule, equivalent to 250 mcg/mL. Confirm the strength on the actual product label.
5. What is the price of Syntropac 250 mcg Injection?
Pricing depends on the supplier, packaging, market and product availability. Contact the supplier for a current quotation.
6. Can Syntropac be administered at home?
It is intended for use under appropriate healthcare supervision because diagnostic sampling must be coordinated and serious hypersensitivity reactions can occur.
7. Is Syntropac available internationally?
Availability and authorization vary by country. Confirm the product’s registration, prescription requirements and import eligibility for the destination market.
This description is for general product information and does not replace professional medical advice, diagnosis or treatment. Syntropac must be administered according to the official product instructions and appropriate clinical protocols. Consult the product leaflet and healthcare professional for full indications, administration instructions, contraindications and safety information.
Last Updated: October 25, 2026
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.